NCT02628067 Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02503111 The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men Status TERMINATED Phase NA
NCT02399813 A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal Status COMPLETED Phase PHASE2
NCT02379039 Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer Status COMPLETED Phase N/A
NCT02280811 T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT02145416 ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy Status COMPLETED Phase N/A
NCT02135419 Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions Status COMPLETED Phase PHASE3
NCT01946139 Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV Status COMPLETED Phase NA
NCT01671488 A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01651949 Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) Status COMPLETED Phase PHASE3
NCT01585428 Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers Status COMPLETED Phase PHASE2
NCT01379872 Assessment of New Radiation Oncology Technologies and Treatments Status COMPLETED Phase N/A
NCT01330186 Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy Status UNKNOWN Phase N/A
NCT01324141 Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer Status TERMINATED Phase PHASE1